Trial Profile
A phase II trial to investigate the efficacy and safety of NC 101 in patients with type 2 diabetes and abnormal liver function
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 08 Jan 2015
Price :
$35
*
At a glance
- Drugs NC 101 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 08 Jan 2015 New trial record